Nutanix reports that 79% of healthcare organisations encounter unmanaged AI and 83% see business risk. NUH’s reported approach is to assess ownership, workflow fit, user support and measurable outcomes before scaling AI beyond pilots.
Published byEdited with GPT-6 LunaImages generated with GPT Image 2
Research answer

Create a landscape editorial hero image for this Studio Global article: How can Singapore healthcare providers address patient-safety and data risks as staff adopt AI faster than hospitals can govern it, given Nu. Article summary: Singapore providers should make approved AI the fastest practical route for staff—not merely prohibit unapproved tools—and expand adoption through small, clinically evaluated pilots supported by governed hybrid infrastru. Topic tags: general, general web, user generated. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, watermarks, charts with fa
Staff may turn to public AI tools when clinical needs move faster than approved systems can be accessed. For Singapore hospitals, the answer is not just to prohibit unapproved use: it is to provide a practical, governed alternative while keeping patient safety and accountability central. 5
Nutanix reports that 79% of healthcare organisations encounter unmanaged AI, while 83% recognise the resulting business risk. 5 The figures describe healthcare organisations, not Singapore hospitals alone: Nutanix’s Healthcare Enterprise Cloud Index is a global survey.
3
That distinction matters. The findings signal a broad governance challenge, but they should not be read as a measure of AI use in Singapore specifically. The local issue raised in the reporting is the gap between clinical demand and timely access to approved tools. 5
Frost & Sullivan’s Rathanesh Ramasundram describes unmanaged AI as a predictable risk when clinical pressure meets slow access to approved tools. 5 A policy cannot solve that access problem by itself. Providers should identify where staff need assistance and make approved tools straightforward to request, access and use in those workflows.
Governance should be built into that route: define who may use a tool, what information may be entered, how its output is reviewed and how AI-supported decisions are recorded. These controls address the patient-data exposure, inaccurate outputs and auditability concerns highlighted in the reporting. 5
Not every healthcare workload has the same infrastructure needs. Nutanix says an intensive-care room may contain 15 to 20 connected devices and generate up to 7 terabytes of data a year. It also notes that sending every signal to a distant cloud can introduce delays and dependence on an external network connection. 1
That makes workload placement part of the governance discussion: providers need to consider where time-sensitive processing should happen and how data is handled across environments. The figures illustrate the potential scale of bedside data; they are not a universal count or volume for every intensive-care room. 1
Start with a defined use case, a clinical owner, an approved data scope and clear criteria for evaluating safety and workflow value. Decide in advance what would justify expansion—and what would mean stopping or revising the pilot.
National University Hospital’s reported approach offers a practical example: AI projects are assessed for business ownership, fit with existing processes, user support and measurable outcomes before moving beyond pilots. 17 This lets providers learn what the tool and the surrounding workflow require before committing to a wider rollout.
A secure system that staff cannot readily use may not address the pressure driving shadow AI. A convenient tool without appropriate safeguards creates different risks. Hospitals therefore need to consider the workflow, infrastructure and governance together—not as separate projects.
The practical aim is to reduce avoidable friction in getting approved AI into use while retaining clinical review, traceability and clear responsibility. Easier access should support accountable care, not replace it.
Studio Global AI
This page includes a source-backed answer you can continue inside Studio Global.
Nutanix reports that 79% of healthcare organisations encounter unmanaged AI and 83% see business risk.
Nutanix reports that 79% of healthcare organisations encounter unmanaged AI and 83% see business risk. NUH’s reported approach is to assess ownership, workflow fit, user support and measurable outcomes before scaling AI beyond pilots.
Nutanix reports that 79% of healthcare organisations encounter unmanaged AI and 83% see business risk. NUH’s reported approach is to assess ownership, workflow fit, user support and measurable outcomes before scaling AI beyond pilots.
Published byEdited with GPT-6 LunaImages generated with GPT Image 2
Research answer

Create a landscape editorial hero image for this Studio Global article: How can Singapore healthcare providers address patient-safety and data risks as staff adopt AI faster than hospitals can govern it, given Nu. Article summary: Singapore providers should make approved AI the fastest practical route for staff—not merely prohibit unapproved tools—and expand adoption through small, clinically evaluated pilots supported by governed hybrid infrastru. Topic tags: general, general web, user generated. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, watermarks, charts with fa
Staff may turn to public AI tools when clinical needs move faster than approved systems can be accessed. For Singapore hospitals, the answer is not just to prohibit unapproved use: it is to provide a practical, governed alternative while keeping patient safety and accountability central. 5
Nutanix reports that 79% of healthcare organisations encounter unmanaged AI, while 83% recognise the resulting business risk. 5 The figures describe healthcare organisations, not Singapore hospitals alone: Nutanix’s Healthcare Enterprise Cloud Index is a global survey.
3
That distinction matters. The findings signal a broad governance challenge, but they should not be read as a measure of AI use in Singapore specifically. The local issue raised in the reporting is the gap between clinical demand and timely access to approved tools. 5
Frost & Sullivan’s Rathanesh Ramasundram describes unmanaged AI as a predictable risk when clinical pressure meets slow access to approved tools. 5 A policy cannot solve that access problem by itself. Providers should identify where staff need assistance and make approved tools straightforward to request, access and use in those workflows.
Governance should be built into that route: define who may use a tool, what information may be entered, how its output is reviewed and how AI-supported decisions are recorded. These controls address the patient-data exposure, inaccurate outputs and auditability concerns highlighted in the reporting. 5
Not every healthcare workload has the same infrastructure needs. Nutanix says an intensive-care room may contain 15 to 20 connected devices and generate up to 7 terabytes of data a year. It also notes that sending every signal to a distant cloud can introduce delays and dependence on an external network connection. 1
That makes workload placement part of the governance discussion: providers need to consider where time-sensitive processing should happen and how data is handled across environments. The figures illustrate the potential scale of bedside data; they are not a universal count or volume for every intensive-care room. 1
Start with a defined use case, a clinical owner, an approved data scope and clear criteria for evaluating safety and workflow value. Decide in advance what would justify expansion—and what would mean stopping or revising the pilot.
National University Hospital’s reported approach offers a practical example: AI projects are assessed for business ownership, fit with existing processes, user support and measurable outcomes before moving beyond pilots. 17 This lets providers learn what the tool and the surrounding workflow require before committing to a wider rollout.
A secure system that staff cannot readily use may not address the pressure driving shadow AI. A convenient tool without appropriate safeguards creates different risks. Hospitals therefore need to consider the workflow, infrastructure and governance together—not as separate projects.
The practical aim is to reduce avoidable friction in getting approved AI into use while retaining clinical review, traceability and clear responsibility. Easier access should support accountable care, not replace it.
Studio Global AI
This page includes a source-backed answer you can continue inside Studio Global.
Nutanix reports that 79% of healthcare organisations encounter unmanaged AI and 83% see business risk.
Nutanix reports that 79% of healthcare organisations encounter unmanaged AI and 83% see business risk. NUH’s reported approach is to assess ownership, workflow fit, user support and measurable outcomes before scaling AI beyond pilots.